PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.\', \'Department of Epidemiology and Public Health, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.\', \'Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.\', \'Abu Dhabi Public Health Center - ADPHC, Abu Dhabi, UAE.\', \'Department of Health, Abu Dhabi, UAE.\', \'Sheikh Khalifa Medical City-Union 71/Purehealth, Abu Dhabi, UAE.\', \'College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.\', \'China National Biotec Group Company Limited, Beijing, China.\', \'G42 Healthcare, Masdar City, Abu Dhabi, UAE.\', \'IROS (Insights Research Organization & Solutions), Masdar City, Abu Dhabi, UAE.\', \'Department of Epidemiology and Public Health, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE. walid.zaher@g42.ai.\', \'College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE. walid.zaher@g42.ai.\', \'G42 Healthcare, Masdar City, Abu Dhabi, UAE. walid.zaher@g42.ai.\', \'IROS (Insights Research Organization & Solutions), Masdar City, Abu Dhabi, UAE. walid.zaher@g42.ai.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-04244-1
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35017530
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all